Page last updated: 2024-08-17

pilocarpine and dapiprazole

pilocarpine has been researched along with dapiprazole in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Doughty, MJ; Lyle, WM1
Geyer, O; Lazar, M; Loewenstein, A; Neudorfer, M; Shalmon, B1
Carpineto, P; Ciancaglini, M; Gallenga, PE; Mastropasqua, L1

Reviews

1 review(s) available for pilocarpine and dapiprazole

ArticleYear
A review of the clinical pharmacokinetics of pilocarpine, moxisylyte (thymoxamine), and dapiprazole in the reversal of diagnostic pupillary dilation.
    Optometry and vision science : official publication of the American Academy of Optometry, 1992, Volume: 69, Issue:5

    Topics: Adrenergic alpha-Antagonists; Humans; Iris; Moxisylyte; Phenylephrine; Pilocarpine; Piperazines; Pupil; Triazoles; Tropicamide

1992

Trials

1 trial(s) available for pilocarpine and dapiprazole

ArticleYear
The additive miotic effects of dapiprazole and pilocarpine.
    Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 1995, Volume: 233, Issue:7

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Double-Blind Method; Drug Synergism; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Miosis; Mydriasis; Ophthalmic Solutions; Parasympathomimetics; Phenylephrine; Pilocarpine; Piperazines; Pupil; Triazoles; Tropicamide

1995

Other Studies

2 other study(ies) available for pilocarpine and dapiprazole

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
The usefulness of dapiprazole, an alpha-adrenergic blocking agent, in pigmentary glaucoma.
    Ophthalmic surgery and lasers, 1996, Volume: 27, Issue:9

    Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aged; Chemotherapy, Adjuvant; Drug Therapy, Combination; Female; Follow-Up Studies; Glaucoma, Open-Angle; Humans; Intraocular Pressure; Male; Middle Aged; Muscarinic Agonists; Ophthalmic Solutions; Pilocarpine; Piperazines; Prospective Studies; Timolol; Treatment Outcome; Triazoles

1996